SARCOIDOSIS, PULMONARY

Clinical trials for SARCOIDOSIS, PULMONARY explained in plain language.

Never miss a new study

Get alerted when new SARCOIDOSIS, PULMONARY trials appear

Sign up with your email to follow new studies for SARCOIDOSIS, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Experimental drug for lung sarcoidosis trial halted early

Disease control Terminated

This study tested a drug called namilumab in 107 adults with chronic pulmonary sarcoidosis, a condition causing lung inflammation. The goal was to see if it could reduce the need for rescue treatments like steroids. The trial was terminated early, so results are limited.

Matched conditions: SARCOIDOSIS, PULMONARY

Phase: PHASE2 • Sponsor: Kinevant Sciences GmbH • Aim: Disease control

Last updated May 13, 2026 15:59 UTC

SARCOIDOSIS, PULMONARY

Get alerted when new SARCOIDOSIS, PULMONARY trials appear

Experimental drug for lung sarcoidosis trial halted early